UK Vision Strategy claims sight loss is set to double

Article

Sight loss could double in the UK by the year 2050, according to predictions from eye health service UK Vision Strategy.

Sight loss could double in the UK by the year 2050, according to predictions from eye health service UK Vision Strategy.

Currently, one in five people aged 75 years and above have developed sight loss, compared to one in two people aged 90 years and above. Experts from the eye care and sight loss divisions are planning to identify improvements in diagnosis and find better treatments to avoid the predicted significant increase.

The UK Vision Strategy is a segment of the World Health Organisation's VISION 2020 initiative, which aspires to eliminate sight loss by the year 2020.

Chairperson of the UK Vision UK Vision Strategy and Chief Executive of Royal National Institute of Blind People, Lesley-Anne Alexander said, "Looking after your eyes by having regular checks is just as important as monitoring your blood pressure or paying a routine visit to the dentist. Problem teeth can usually be repaired or replaced but with eyes, the solution is rarely so simple. Whatever your age or health situation, if you haven't had your eyes checked recently, take action now and you could well prevent sight loss problems in later life".

Chairperson of VISION 2020 UK Nick Astbury, said, " Losing your sight should never become a naturally accepted part of getting older. Over half of all sight loss in this country can be avoided if it is picked up early and treated. Taking regular exercise, eating a healthy diet and stopping smoking is also vital for keeping your eyes healthy".

Recent Videos
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Enrico Borrelli, MD, FEBO, speaks at EURETINA
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
© 2024 MJH Life Sciences

All rights reserved.